Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?
Intestinal Research · 31.10.2026 · 24 (4) · 610-611
DOI: 10.5217/ir.2026.00311 ↗Kurz gefasst
Editorial in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Yong Eun Park. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Ko…. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea. ready200@paik.ac.kr.
Zitieren
APA
Park, Y. E. (2026). Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?. Intestinal Research, 24(4), 610-611. https://doi.org/10.5217/ir.2026.00311
Vancouver
Park YE. Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?. Intestinal Research. 2026;24(4):610-611. doi:10.5217/ir.2026.00311
BibTeX
@article{Park2026,
author = {Park, Yong Eun},
title = {Beyond first-line biologic therapy: does treatment sequence matter in ulcerative colitis?},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {4},
pages = {610--611},
doi = {10.5217/ir.2026.00311}
}
EUVIMED